Afuco™ Anti-Human Chemokine ADCC Therapeutic Antibody (E6011), ADCC Enhanced
Anti-Chemokine ADCC Enhanced Antibody (E6011) is an ADCC enhanced antibody produced by our Afuco™ platform. E 6011 (KANAb 001) is a chemokine-targeted monoclonal antibody used for the treatment of inflammatory bowel diseases, crohn's disease and rheumatoid arthritis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-154CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | Chemokine |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |